| Detailed information |
|---|
| CancerLivER ID | 2148 |
| Biomarker | miR-129* |
| Biomarker Name/Symbol (given in Publication) | miR-129* |
| Biomolecule | miRNA |
| Subject | Human |
| Degree of Validity | HCC biomarkers regardless of virus infection; but not validated on independent datasets |
| Experimental Condition | Normal vs HCC, liver cancer |
| Cancer type | Hepatocellular carcinoma |
| Regulation | Downregulated in the HCC v/s non-tumor |
| Level of significance | p < 0.05 |
| Source | Tissue |
| PMID | 23205106 |
| Type of Biomarker | Diagnostic |
| Pathway | NA |
| Cohort | 40 primary HCC patients and 6 metastatic liver cancer patients. |
| Sensitivity | NA |
| Specificity | NA |
| Accuracy | NA |
| AUC | NA |
| Disease | Human HCC |
| Year of Publication | 2012 |
| Clinical trial | NO |
| Clinical trial (NCT Number) | NA |